Listed

Alphatec Holdings, Inc.

ATECNasdaqCIK 1350653HealthcareFiscal year ends Dec 31

Reports and events: 345 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Alphatec Holdings, Inc., Reports and events
FiledFormWhat it isAccession number
2026-10-2916:21 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-26-437830
2026-08-0416:57 ET10-QQuarterly reportPeriod 2026-06-300001193125-26-333051
2026-08-0416:19 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-26-332870
2026-06-1116:13 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-26-267552
2026-05-0516:56 ET10-QQuarterly reportPeriod 2026-03-310001193125-26-206683
2026-05-0516:28 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-26-206530
2026-04-2916:26 ETDEF 14AProxy statementPeriod 2026-06-100001193125-26-191867
2026-03-0316:14 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-26-088220
2026-02-2416:58 ET10-KAnnual reportPeriod 2025-12-310001193125-26-067393
2026-02-2416:19 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-26-067062
2026-01-1209:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-26-009910
2025-12-1718:25 ETSCHEDULE 13D/AOwnership report, active investor, amended0001193125-25-323158
2025-11-0709:10 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-25-271197
2025-10-3016:57 ET10-QQuarterly reportPeriod 2025-09-300001193125-25-258790
2025-10-3016:23 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-25-258609
2025-07-3116:51 ET10-QQuarterly reportPeriod 2025-06-300000950170-25-100963
2025-07-3116:19 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-25-100924
2025-06-1316:03 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0000950170-25-086130
2025-05-0116:57 ET10-QQuarterly reportPeriod 2025-03-310000950170-25-061974
2025-05-0116:17 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-25-061859
2025-04-2516:14 ETDEF 14AProxy statementPeriod 2025-06-110000950170-25-058724
2025-04-2321:45 ETSCHEDULE 13D/AOwnership report, active investor, amended0000950170-25-057646
2025-04-1120:34 ETSCHEDULE 13D/AOwnership report, active investor, amended0000950170-25-053434
2025-04-0316:23 ET8-K5.02 Departure or appointment of officers or directors0000950170-25-050434
2025-03-1416:03 ET8-K8.01 Other events0001193125-25-054786
2025-03-0717:27 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001193125-25-049998
2025-03-0516:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-25-047166
2025-03-0316:02 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-25-044094
2025-02-2617:10 ET10-KAnnual reportPeriod 2024-12-310000950170-25-027916
2025-02-2616:20 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-25-027786
2025-02-0609:01 ETSCHEDULE 13D/AOwnership report, active investor, amended0000950170-25-015038
2025-01-1309:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-25-004614
2024-11-1220:04 ETSC 13D/AOwnership report, active investor, amended0001193125-24-256228
2024-10-3016:54 ET10-QQuarterly reportPeriod 2024-09-300000950170-24-119083
2024-10-3016:20 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0000950170-24-119022
2024-07-3116:57 ET10-QQuarterly reportPeriod 2024-06-300000950170-24-088670
2024-07-3116:20 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-24-088609
2024-06-1718:09 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0000950170-24-073859
2024-05-0716:59 ET10-QQuarterly reportPeriod 2024-03-310000950170-24-054691
2024-05-0716:20 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-24-054549
2024-04-2616:44 ETDEF 14AProxy statementPeriod 2024-06-120000950170-24-049245
2024-03-2219:57 ETSC 13D/AOwnership report, active investor, amended0001193125-24-075553
2024-03-1917:05 ET8-K7.01 Regulation FD disclosure0000950170-24-033642
2024-02-2716:52 ET10-KAnnual reportPeriod 2023-12-310000950170-24-021302
2024-02-2716:22 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-24-021203
2024-01-0809:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-24-002736
2024-01-0309:00 ET8-K5.02 Departure or appointment of officers or directors0000950170-24-000544
2023-11-0616:51 ET10-QQuarterly reportPeriod 2023-09-300000950170-23-059489
2023-11-0616:19 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-059413
2023-10-2717:31 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-23-264201

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 17:13 ET. Listed shows no prices and gives no investment advice.